Abstract
The collagen-induced arthritis (CIA) mouse model is the most commonly studied autoimmune model of rheumatoid arthritis. Autoimmune arthritis is induced in this model by immunization with an emulsion of complete Freund's adjuvant and type II collagen (CII). This protocol describes the steps necessary for acquisition, handling and preparation of CII, as well as selection of mouse strains, proper immunization technique and evaluation of the arthritis incidence and severity. Typically, the first signs of arthritis appear in this model 21–28 days after immunization, and identification of the arthritic limbs is not difficult. Using the protocol described, the investigator should be able to reproducibly induce a high incidence of CIA in various strains of genetically susceptible mice as well as learn how to critically evaluate the pathology of the disease. The total time for the preparation of reagents and the immunization of ten mice is about 1.5 h.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Brand, D.D. Rodent models of rheumatoid arthritis. Comp. Med. 55, 114–122 (2005).
Finnegan, A., Mikecz, K., Tao, P. & Glant, T.T. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J. Immunol. 163, 5383–5390 (1999).
Koga, T. et al. Acute joint inflammation in mice after systemic injection of the cell wall, its peptidoglycan, and chemically defined peptidoglycan subunits from various bacteria. Infect. Immun. 50, 27–34 (1985).
Courtenay, J.S., Dallman, M.J., Dayan, A.D., Martin, A. & Mosedale, B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 283, 666–668 (1980).
Brackertz, D., Mitchell, G.F. & Mackay, I.R. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum. 20, 841–850 (1977).
Hopkins, S.J., Freemont, A.J. & Jayson, M.I. Pristane-induced arthritis in Balb/c mice. I. Clinical and histological features of the arthropathy. Rheumatol. Int. 5, 21–28 (1984).
Butler, D.M. et al. DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J. Immunol. 159, 2867–2876 (1997).
Kouskoff, V. et al. Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811–822 (1996).
Holmdahl, R., Jansson, L., Larsson, E., Rubin, K. & Klareskog, L. Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum. 29, 106–113 (1985).
Boissier, M.C., Feng, X.Z., Carlioz, A., Roudier, R. & Fournier, C. Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann. Rheum. Dis. 46, 691–700 (1987).
Londei, M. et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 86, 636–640 (1989).
Kim, H.Y. et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum. 42, 2085–2093 (1999).
Terato, K. et al. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum. 33, 1493–1500 (1990).
Kim, W.U. et al. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J. Rheumatol. 27, 575–581 (2000).
Watson, W.C., Tooms, R.E., Carnesale, P.G. & Dutkowsky, J.P. A case of germinal center formation by CD45RO T and CD20 B lymphocytes in rheumatoid arthritic subchondral bone: proposal for a two-compartment model of immune-mediated disease with implications for immunotherapeutic strategies. Clin. Immunol. Immunopathol. 73, 27–37 (1994).
Rosloniec, E.F. et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J. Exp. Med. 185, 1113–1122 (1997).
Rosloniec, E.F. et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J. Immunol. 160, 2573–2578 (1998).
Michaëlsson, E., Andersson, M., Engström, Å. & Holmdahl, R. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur. J. Immunol. 22, 1819–1825 (1992).
Myers, L.K. et al. Collagen-induced arthritis in B10.RIII mice (H-2r): identification of an arthritogenic T-cell determinant. Immunology 84, 509–513 (1995).
Brand, D.D. et al. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine α1(II)-CB11 in H-2q mice. J. Immunol. 152, 3088–3097 (1994).
Rosloniec, E.F., Whittington, K.B., Brand, D.D., Myers, L.K. & Stuart, J.M. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen induced arthritis. Cell. Immunol. 172, 21–28 (1996).
Rosloniec, E.F., Whittington, K.B., Zaller, D.M. & Kang, A.H. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. J. Immunol. 168, 253–259 (2002).
Bajtner, E., Nandakumar, K.S., Engstrom, A. & Holmdahl, R. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res. Ther. 7, R1148–R1157 (2005).
Brand, D.D. et al. Autoantibodies to murine type II collagen in collagen induced arthritis: a comparison of susceptible and non susceptible strains. J. Immunol. 157, 5178–5184 (1996).
Burkhardt, H. et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum. 46, 2339–2348 (2002).
Holmdahl, R., Jansson, L., Andersson, M. & Jonsson, R. Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice. Clin. Exp. Immunol. 88, 467–472 (1992).
Nordling, C., Karlsson, P.A., Jansson, L., Holmdahl, R. & Klareskog, L. Characterization of a spontaneously occurring arthritis in male DBA/1 mice. Arthritis Rheum. 35, 717–722 (1992).
Guedez, Y.B. et al. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 44, 2413–2424 (2001).
Chu, C.Q., Song, Z., Mayton, L., Wu, B. & Wooley, P.H. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann. Rheum. Dis. 62, 983–990 (2003).
Pan, M., Kang, I., Craft, J. & Yin, Z. Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response. J. Clin. Immunol. 24, 481–491 (2004).
Campbell, I.K., Hamilton, J.A. & Wicks, I.P. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur. J. Immunol. 30, 1568–1575 (2000).
Kai, H. et al. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology 118, 233–239 (2006).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Brand, D., Latham, K. & Rosloniec, E. Collagen-induced arthritis. Nat Protoc 2, 1269–1275 (2007). https://doi.org/10.1038/nprot.2007.173
Published:
Issue date:
DOI: https://doi.org/10.1038/nprot.2007.173


